decisionhealth Newsletters, Answer Books - 2009 Issue 1 (January)
Coumadin Clinics / Tips for billing Coumadin visits to Medicare
Subscribe or sign in to view the full article.
Article Overview
This short article explains Medicare-related billing considerations for Coumadin management visits in a clinic setting. It addresses general compliance topics for evaluation and management services, laboratory testing under Medicare, and the role of CLIA-waived test reporting. The piece is aimed at coders, billing staff, and practices that bill anticoagulation-related visits and want to understand the Medicare-specific guidance discussed in the article.
Why This Topic Matters
Accurate Medicare reporting for Coumadin clinic visits can affect claim processing and compliance. Understanding the article helps practices recognize when laboratory test reporting and modifier use are discussed in the context of Medicare billing.
What You Will Learn
- How the article frames Medicare billing considerations for Coumadin management visits
- What general compliance issues are discussed for related E/M services
- How the article treats laboratory test reporting and CLIA-waived testing under Medicare
- Who the guidance is intended to help in a billing or coding workflow
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle teams
- Primary care practices
- Anticoagulation/Coumadin clinics
Codes Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com